Finance

Lists
Q3 2026 earnings • released • EPS miss -323.91% • Revenue miss -7.97%
See results
INVA:NASDAQ
Innoviva Inc
$ 19.10
-0.73%
(-0.14) 1D
$ 19.10
0.00% (0.00)
After hours
Closed: 11-р сарын 6, 16:00:01 (GMT-5)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INVA...
Open
$ 19.54
High
$ 19.87
Low
$ 19.02
Mkt. cap
1.38 тэрбум
Avg. vol.
762.00 мян
Volume
1.65 сая
P/E ratio
4.61
52-wk high
$ 25.14
52-wk low
$ 19.00
EPS
$ 4.15
Beta
0.38
Shares outstanding
71.08 сая
No. of employees
159
Open
$ 19.54
High
$ 19.87
Low
$ 19.02
Mkt. cap
1.38 тэрбум
Avg. vol.
762.00 мян
Volume
1.65 сая
P/E ratio
4.61
52-wk high
$ 25.14
52-wk low
$ 19.00
EPS
$ 4.15
Beta
0.38
Shares outstanding
71.08 сая
No. of employees
159
News stories
From web sources and news partners
About Innoviva Inc
CEO-
Employees159
Founded1996
HeadquartersSouth San Francisco, Калифорни, Америкийн Нэгдсэн Улс
SectorHealth Care
IndustryPharmaceutical industry
Websiteinva.com
Analyst ratings
Based on 3 analysts giving stock ratings to INVA in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for INVA in the last 3 months.
Highest
Current $ 19.10
$ 46.00 (+140.84%)
Average
$ 38.00 (+98.95%)
Lowest
$ 34.00 (+78.01%)
Analyst
Recommendation
Action
Price target
Projected
Date
Les Sulewski
Oppenheimer
Buy
Reiterated
$ 34.00
+78%
11/05/2026
Unknown Analyst
Oppenheimer
Buy
Initiated
$ 35.00
+83.2%
09/23/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
$ 34.00
+78%
08/20/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$ 46.00
+140.8%
08/10/2026
Julian Harrison
BTIG
Buy
Maintained
$ 42.00
+119.9%
08/05/2026
Asad Haider
Goldman Sachs
Sell
Maintained
$ 18.00
-5.8%
05/06/2026
Trevor Allred
Oppenheimer
Buy
Downgraded
$ 35.00
+83.2%
02/26/2026
Last report
2026 оны 11-р сарын 4
Fiscal period
Q3 2026
-$ 1.03 / $ 0.46
-323.91%miss
Revenue / Est. (USD)
106.12 сая / 115.31 сая
-7.97%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
2026 оны 9-р сар
Revenue
114.61 сая
97.99 сая
119.59 сая
106.12 сая
Cost of goods sold
36.18 сая
14.46 сая
21.45 сая
15.04 сая
Cost of revenue
36.18 сая
14.46 сая
21.45 сая
15.04 сая
Research and development expenses
-
5.24 сая
5.19 сая
5.21 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
32.08 сая
32.44 сая
34.57 сая
37.02 сая
Operating expense
38.71 сая
44.23 сая
46.39 сая
48.93 сая
Total operating expenses
74.89 сая
58.69 сая
67.84 сая
63.97 сая
Operating income
39.72 сая
39.30 сая
51.76 сая
42.15 сая
Other non operating income
-612.00 мян
-366.00 мян
-15.00 мян
-118.00 мян
EBT including unusual items
195.04 сая
234.56 сая
-108.02 сая
-97.61 сая
EBT excluding unusual items
41.95 сая
44.49 сая
53.87 сая
41.88 сая
Income tax expense
30.88 сая
47.97 сая
-24.60 сая
-23.72 сая
Effective tax rate
15.83%
20.45%
22.77%
24.30%
Other operating expenses
-
-
-
-
Net income
164.15 сая
186.60 сая
-83.42 сая
-73.89 сая
Net profit margin
143.22%
190.41%
-69.75%
-69.63%
Earnings per share
0.47
0.47
0.56
-
Interest and investment income
6.15 сая
10.99 сая
7.60 сая
5.32 сая
Interest expense
-3.31 сая
-5.44 сая
-5.47 сая
-5.47 сая
Net interest expenses
2.84 сая
5.55 сая
2.13 сая
-156.00 мян
Depreciation and amortization charges
-
-
-
-
EBITDA
46.39 сая
45.89 сая
58.45 сая
48.75 сая
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google аппс